Tactile Systems Technology (TCMD) Common Equity (2015 - 2026)
Tactile Systems Technology's (TCMD) quarterly Common Equity came in at $217.9 million in Q1 2026, up 5.95% year-on-year from $205.6 million in Q1 2025, and little changed on a QoQ basis from $218.9 million in Q4 2025.
Tactile Systems Technology (TCMD) Common Equity (2015 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 12 years of Common Equity data on file, last reported at $217.9 million in Q1 2026.
- On a quarterly basis, Common Equity rose 5.95% year-over-year to $217.9 million in Q1 2026; TTM through Mar 2026 was $217.9 million, a 5.95% increase from a year earlier, with the FY2025 full-year figure at $218.9 million, up 1.06% from the prior year.
- Common Equity for Q1 2026 stood at $217.9 million, roughly flat from $218.9 million in the prior quarter.
- Over the last five years, Common Equity for TCMD reached as high as $218.9 million in Q4 2025 and fell as low as $114.1 million in Q2 2022.
- Historically, Common Equity has averaged $177.5 million across 5 years, with a median of $193.6 million in 2023.
- Across the five-year window, Common Equity dropped 14.01% in 2022 and surged 59.82% in 2023, its largest moves.
- Year by year, Common Equity stood at $121.4 million in 2022, then surged by 59.51% to $193.6 million in 2023, then increased by 11.85% to $216.6 million in 2024, then gained by 1.06% to $218.9 million in 2025, then decreased by 0.47% to $217.9 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $217.9 million in Q1 2026, $218.9 million in Q4 2025, and $204.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Tactile Systems Technology | 619.08 Mn | 528.88 Mn | 57.61 Mn | 217.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 217.87 Mn |
| Dec 31, 2025 | 218.90 Mn |
| Sep 30, 2025 | 204.95 Mn |
| Jun 30, 2025 | 194.93 Mn |
| Mar 31, 2025 | 205.63 Mn |
| Dec 31, 2024 | 216.60 Mn |
| Sep 30, 2024 | 207.90 Mn |
| Jun 30, 2024 | 200.68 Mn |
| Mar 31, 2024 | 193.47 Mn |
| Dec 31, 2023 | 193.64 Mn |
| Sep 30, 2023 | 182.83 Mn |
| Jun 30, 2023 | 158.76 Mn |
| Mar 31, 2023 | 156.16 Mn |
| Dec 31, 2022 | 121.40 Mn |
| Sep 30, 2022 | 114.40 Mn |
| Jun 30, 2022 | 114.12 Mn |
| Mar 31, 2022 | 114.98 Mn |
| Dec 31, 2021 | 128.23 Mn |
| Sep 30, 2021 | 132.11 Mn |
| Jun 30, 2021 | 132.72 Mn |